Pharma Stocks
-
Avadel Pharmaceuticals (AVDL): Assessing Valuation Following Strong Recent Share Gains
Avadel Pharmaceuticals (AVDL) has recently drawn attention in the stock market, especially with its steady gains over the past month…
Read More » -
Assessing Amneal Pharmaceuticals (AMRX) Valuation After Strengthened Balance Sheet and Pipeline Expansion
Amneal Pharmaceuticals (AMRX) has taken significant steps recently to strengthen its capital structure, focusing on steady debt reduction, improved cash…
Read More » -
Aurobindo Pharma Sees 13.1% Surge in Open Interest, Reaching 65,984 Contracts
Aurobindo Pharma Ltd. has seen a significant rise in open interest, reaching 65,984 contracts, alongside a trading volume of 39,621…
Read More » -
Pharma stocks in focus as Trump eyes probe into foreign drug pricing practices
Pharmaceutical stocks are in focus on Thursday morning following reports that US President Donald Trump has ordered an investigation into…
Read More » -
Another >US$100bn biotech that is facing the cliff like its peers, but might be safer
$100bn biotechs like Vertex Pharmaceuticals (NDQ:VRTX) typically get to their position through ‘blockbuster drugs’ with periods of market exclusivity, which…
Read More » -
Avadel Pharmaceuticals Soars as Alkermes Announces $2.1 Billion Acquisition
DUBLIN, IRELAND – October 22, 2025 – Avadel Pharmaceuticals (NASDAQ: AVDL) shareholders are celebrating today as Alkermes plc (NASDAQ: ALKS)…
Read More » -
Ascendis Pharma (NasdaqGS:ASND): Evaluating Valuation as Analyst Confidence Rises on Key EMA Filing
Ascendis Pharma (NasdaqGS:ASND) recently submitted a Marketing Authorisation Application to the European Medicines Agency for TransCon CNP, targeting children with…
Read More » -
Shuttle Pharma Signs LOI to Acquire Molecule.ai for $10M
Shuttle Pharmaceuticals (NASDAQ:SHPH) announced a definitive Letter of Intent dated October 21,…
Read More » -
Did Sofdra Launch Progress and a Leadership Change Just Shift Botanix Pharmaceuticals’ (ASX:BOT) Investment Narrative?
Botanix Pharmaceuticals recently provided a comprehensive update on its quarterly activities and progress of the Sofdra® (sofpironium) topical gel launch,…
Read More » -
Neuren Pharmaceuticals (ASX:NEU): Assessing Valuation After FDA Fast Track Win for Rare Disease Therapy
Neuren Pharmaceuticals (ASX:NEU) caught attention after announcing its candidate NNZ-2591 received Fast Track designation from the US FDA for both…
Read More »